Prescription Drugs

Updates

protected content Breakdown of ERIC Health Care Cost Roadmap Letter, Major PBM Mandates Point-of-Sale Rebates, and Mor

It’s another big week for health care in D.C., as we have the rollout of the President’s (mostly dead-on-arrival) budget proposal, more volleys in the prescription drug costs debate, and more… More

ERIC Outlines Top Health Priorities for Congress in New Letter

ERIC submitted a letter to the U.S. Senate, Committee on Health, Education, Labor and Pensions on specific legislative solutions for reducing health care costs… More

protected content Alert: Oklahoma Bills would Impact Pharmacy Benefit Plans

Two bills on the move in Oklahoma, Senate Bill 841 and House Bill 2632, would have a big impact on pharmacy benefit plans in the state… More

protected content Rx Rebate Alert – GOP Senator Introduces Bill to End Private Sector PBM Rebates

Just a quick heads up – last night, this draft legislation began circulating, courtesy of Senator Mike Braun (R-IN). Dubbed the “Drug Price Transparency Act,” this bill would do the following… More

ERIC Submits Comments on Maine Biosimilar Bill

Today, ERIC submitted comments to the Maine House Committee on Health Coverage, Insurance and Financial Services regarding Legislative Document 659, which would allow pharmacists to make biosimilar substitutions… More

See All Updates

Amicus Briefs

protected content Rx rebate mayhem, Amicus filed in 5th Circuit, New caddy data, and more!

Yesterday, the Administration announced its proposed rule to lower prescription drug prices and out-of-pocket costs “by encouraging manufacturers to pass discounts directly on to patients and bringing new transparency to prescription drug markets” … More

More Amicus Briefs

Court Rulings

protected content SCOTUS Delivers This June’s Verdict on the ACA … and Contraceptives

Today the Supreme Court of the United States, in its last decision of the term, found that the HHS regulations imposing the “no-cost contraceptives” requirement of the Affordable Care Act violate the Religious Freedom Restoration Act of 1993 with respect to three for-profit, closely-held corporations. … More

More Court Rulings

ERIC Surveys

protected content Member Survey on Sabbatical Leave, Wellness & PBMs

ERIC conducted a survey of its members, on sabbatical leave, wellness programs, and the use of pharmacy benefit manager (PBM) for your prescription drug benefit… More

More ERIC Surveys

Judicial Documents

protected content SCOTUS Delivers This June’s Verdict on the ACA … and Contraceptives

Today the Supreme Court of the United States, in its last decision of the term, found that the HHS regulations imposing the “no-cost contraceptives” requirement of the Affordable Care Act violate the Religious Freedom Restoration Act of 1993 with respect to three for-profit, closely-held corporations. … More

More Judicial Documents

Legislative Documents

protected content Review of Health Provisions Included in President Obama’s FY 2016 Budget

Today the president released his proposed budget ideas for Fiscal Year 2016, which starts this coming October 1. From my vantage point … More

protected content Analysis of Health-Related Proposals in Obama Administration’s FY 2014 Budget

As promised, President Obama formally released his budget yesterday for Fiscal Year 2014 (which starts October 1, 2013 and runs through September 30, 2014.) Although the really earth-shaking developments are mostly on the retirement side, there were nonetheless some interesting developments on the health front … More

Key Health Care Reform Legislative Documents (H.R. 3590 and H.R. 4872)

The House and Senate on March 25, 2010, approved the Health Care and Education Reconciliation Act (H.R. 4872), the "sidecar" reconciliation… More

More Legislative Documents

Letters to Agencies

ERIC Submits Comments on Maine Biosimilar Bill

Today, ERIC submitted comments to the Maine House Committee on Health Coverage, Insurance and Financial Services regarding Legislative Document 659, which would allow pharmacists to make biosimilar substitutions… More

Alert: ERIC Submits Comments on Arkansas Biosimilar Bill

Today, ERIC submitted comments to the Arkansas House Public Health, Welfare and Labor Committee on House Bill 1269, which would allow pharmacists to make biosimilar substitutions… More

ERIC Submits Comments to HHS on the President’s “American Patients First” Blueprint

Today, ERIC submitted comments to the Department of Health and Human Services (HHS) in response to its Request for Information related to the HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs… More

ERIC Submits Comments on Mississippi’s Part 2640 Proposed Rules

On behalf of The ERISA Industry Committee (ERIC), thank you for accepting input from interested stakeholders as you consider the Mississippi State Board of Medical Licensure proposed rules for Part 2640… More

ERIC Submits Comments on Proposed Changes to Medicare Prescription Drug Program

The ERISA Industry Committee (ERIC) submitted comments to the Centers for Medicare & Medicaid Services (CMS) on proposed changes to the Medicare prescription drug program… More

ERIC Urges CMS to Reconsider Restrictive Requirements on Part D Automatic Prescription Refills

ERIC, along with several other employer business groups, on June 11 wrote to the Centers for Medicare and Medicaid Services urging the agency to reconsider unnecessarily restrictive requirements on automatic prescription refill programs under Medicare Part D. … More

More Letters to Agencies

Letters to Congress

ERIC Outlines Top Health Priorities for Congress in New Letter

ERIC submitted a letter to the U.S. Senate, Committee on Health, Education, Labor and Pensions on specific legislative solutions for reducing health care costs… More

ERIC Victory: President Signs Bill Banning Pharmacy Gag Clauses

ERIC applauds lawmakers and the Administration for coming together and banning so-called “gag clauses” in group health plans and individual market health insurance plans… More

ERIC Sends Letter to Hill Opposing ESRD Provision in Opioids Bill

ERIC and members of the National Coalition on Benefits sent a letter reiterating our strong opposition to the end-stage renal disease (ESRD) provision in the House-passed version of the opioids bill… More

ERIC Works to Make Prescription Drug Costs More Transparent

ERIC sent a letter to the U.S. Senate urging lawmakers to support S. 2554, the “Patient Right to Know Drug Prices Act.” The bill would ban so-called “gag clauses” in group health plans and individual market health insurance plans. These clauses prevent pharmacists from informing a patient that filling a prescription might be cheaper if the patient pays cash, rather than the negotiated copay under their insurance coverage… More

protected content HHS Nominee Hearing Coming, End-of-Year Health Care Legislation, HSA Action, and More

On November 29 at 9:30am, the Senate Health, Education, Labor and Pensions (HELP) Committee will hold a hearing on Alex Azar’s nomination to be Secretary of Health and Human Services (HHS). The Committee hearing is a “courtesy hearing”—it will not be a vote on Azar’s nomination (the Senate Finance Committee is the one that will have to report Azar out to the Senate floor). Azar’s nomination to fill the vacancy left by Secretary Tom Price was announced on November 13 by President Trump… More

ERIC and Over 400 Organizations Express Opposition to House Health Care Reform Bill

ERIC and over 400 other companies and organizations on November 4 wrote to House Speaker Nancy Pelosi (D-CA) and Minority Leader John… More

More Letters to Congress

Press Releases

ERIC Outlines Top Health Priorities for Congress in New Letter

ERIC submitted a letter to the U.S. Senate, Committee on Health, Education, Labor and Pensions on specific legislative solutions for reducing health care costs… More

ERIC Victory: President Signs Bill Banning Pharmacy Gag Clauses

ERIC applauds lawmakers and the Administration for coming together and banning so-called “gag clauses” in group health plans and individual market health insurance plans… More

ERIC is Working to Make Prescription Drugs More Affordable

The ERISA Industry Committee (ERIC) today submitted comments to the Department of Health and Human Services (HHS) in response to its request for information related to the HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs… More

ERIC Responds to Mercer Survey of Employer-Sponsored Plans

Today’s release of data from Mercer’s National Survey of Employer-Sponsored Health Plans, highlights the important role large employers’ play as plan sponsors… More

More Press Releases